CG Oncology Initiates Expanded Access Program for Cretostimogene Grenadenorepvec

Go back to CG Oncology Initiates Expanded Access Program for Cretostimogene Grenadenorepvec
(NASDAQ: CGON) Delayed: 71.05 -2.68 (3.63%)
Previous Close $73.73    52 Week High
Open $75.07    52 Week Low
Day High $77.00    P/E N/A 
Day Low $70.54    EPS
Volume 1,405,178